BOSTON,March 5,2025--Bioheng Therapeutics US LLC ("Bioheng"),a clinical-stage biotech company dedicated to developing innovative universal CAR-T cell therapies,today announced that the U.S.

SINGAPORE,March 5,2025--The Laughing Cowhas been honored with the Prestigious Brands of Asia 2024-25 award in the FMCG - Cheese category. This recognition,presented at the Global Business Symposium ho

BARCELONA,Spain,March 5,2025-- Fibocom (Stock code:300638),a global leading provider of AIoT solutions and wireless communication modules,demonstrated its MTK T830-based 5G Module FG370 with MediaTek

NEW YORK,March 5,2025-- The New York Stock Exchange (NYSE) is proud to offer a daily pre-market update directly from the NYSE Trading Floor. Access today\'s NYSE Pre-market update for market insight

The new solution allows developers to use any AI model to create voice agents optimized for ultra-low latency and natural conversation flow

PhaseIb trial to evaluate CS5001 in combination with R-CHOP as a first-line treatment for diffuse large B-cell lymphoma (DLBCL),aiming to reshape the standard-of-care landscape.